Sports Drug Testing & Cannabis

WADA thresholds, league-by-league rules, out-of-competition protections, and what athletes in legal states need to know.

MW
Cannabis Policy Analyst at ZenWeedGuide. Expert in cannabis legislation, travel regulations, and dispensary operations across the US and internationally.

Key Findings

How Sports Drug Testing Works

Elite sports drug testing operates through a multi-layered system involving international governing bodies, national anti-doping agencies, and individual league policies. For cannabis specifically, the rules vary enormously depending on the sport, the competition level, and the country the athlete competes in.

The World Anti-Doping Agency (WADA) sets the international baseline via the World Anti-Doping Code, which is adopted by Olympic sports, major international federations, and national Olympic committees. However, North American professional leagues — the NFL, NBA, MLB, and NHL — are private employers and negotiate their own testing programs through collective bargaining agreements (CBAs). This creates a fragmented landscape where the same substance can be treated very differently depending on the sport.

Most tests in elite sports use urine as the primary matrix. Blood and saliva testing are increasingly used for specific purposes (growth hormone, in-competition alcohol), but urine immunoassay followed by GC-MS or LC-MS/MS confirmation remains the standard for cannabis.

WADA Cannabis Rules in Detail

Cannabis and cannabinoids (except CBD) appear in WADA’s Prohibited List under Section S8: Cannabinoids, with the specific designation “in-competition only.” This means WADA does not seek to govern what athletes do in their private time off-season; the concern is performance modification during competition itself.

The urinary threshold was revised significantly in 2013 when WADA raised the cutoff from 15 ng/mL to 150 ng/mL of urinary carboxy-THC (11-nor-9-carboxy-THC, or THC-COOH). The intent was to avoid sanctioning athletes for use that occurred days or weeks before competition, focusing instead on genuine in-competition intoxication. At 150 ng/mL, a casual user who abstained for 48–72 hours before competition would typically test negative, though heavy chronic users may still exceed this threshold.

WADA defines “in-competition” as the period commencing 12 hours before a scheduled competition through the end of the competition and the sample collection process. Practically, an athlete who smoked the night before a morning competition may still test positive depending on their usage history and metabolism.

Sanctions for a first cannabis violation under the WADA Code can range from a reprimand to a two-year ban depending on the athlete’s degree of fault. Cases where athletes demonstrate the substance was not performance-enhancing and was used out of competition (prior to the 12-hour window) frequently result in reduced sanctions.

Sport-by-Sport Rules Table

Sport / League Governing Body Cannabis Status Threshold Testing Window First Offense
Olympic Sports WADA / IOC Prohibited in-competition 150 ng/mL urine THC-COOH In-competition only Reprimand to 2-year ban
NFL NFL / NFLPA CBA Restricted (pre-season test window) 35 ng/mL April 20 – August 9 only Treatment program, no suspension (1st)
NBA NBA / NBPA CBA No suspension for use (treatment program) Not publicly specified First two months of season only Entry into treatment program
MLB MLB / MLBPA Removed from banned list (2019) N/A (not tested) Not tested N/A
NHL NHL / NHLPA Treatment-based, not discipline Not publicly specified Random year-round Mandatory assistance program
NCAA NCAA Banned at championships 15 ng/mL Championship/bowl events 1-year eligibility suspension
UFC / MMA USADA (USAC post-2023) Prohibited in-competition 150 ng/mL Primarily in-competition 6-month suspension (typical)
WADA-governed cycling (UCI) WADA / UCI Prohibited in-competition 150 ng/mL In-competition only Reprimand to 2-year ban
World Athletics (track & field) WADA / World Athletics Prohibited in-competition 150 ng/mL In-competition only Reprimand to 2-year ban

NFL: The Most Athlete-Friendly Major League Policy

The NFL has shifted substantially toward a treatment-rather-than-punishment framework in its most recent CBA. Under the current agreement, cannabis testing for players is limited to a specific window: April 20 through August 9 (the pre-season period). Outside of this window, the NFL does not test for cannabis unless a player is already in the league’s intervention program or has violated its substance abuse policy previously.

The cutoff level used by the NFL (35 ng/mL) is stricter than WADA’s 150 ng/mL, which means a player who consumed cannabis two weeks before the pre-season testing window could theoretically still register a positive if they are a heavy user. Players who test positive for the first time are placed in a treatment program and are not suspended. Repeat violations escalate to fines and potential game suspensions only at the third violation level.

This is a remarkable shift from earlier eras when cannabis positives resulted in multi-game suspensions and public disclosure. The change reflects both player pressure and the evolving legal landscape — more than 40 states have legalized cannabis for medical or adult use, and the NFL’s old approach was increasingly difficult to defend publicly.

NBA and NHL: Wellness Models

The NBA moved to a wellness-focused cannabis policy in the 2020 CBA extension, suspending testing entirely during the COVID bubble and not fully reinstating punitive testing afterward. The league now uses a treatment model where positive tests trigger participation in an assistance program rather than suspension. Testing occurs only during the first two months of the regular season, leaving a large portion of the calendar unmonitored.

The NHL has similarly adopted a treatment-first approach. Players who test positive are referred to the league’s Player Assistance Program (PAP) rather than facing disciplinary action. The NHL does conduct year-round random testing, but the outcomes are oriented toward support rather than sanction.

MLB: Cannabis Removed from Banned List

In 2019, Major League Baseball became the first major North American professional league to remove cannabis entirely from its banned substances list. MLB players are no longer tested for cannabis, and use does not trigger any league-level consequence. This reflects both the legal reality in many US states and Canada (where multiple MLB teams play) and a deliberate policy shift by the league and the MLBPA.

It is worth noting that MLB still tests rigorously for performance-enhancing drugs (anabolic steroids, peptide hormones, stimulants) and maintains one of the stricter PED programs in professional sports. Cannabis simply is no longer part of that program.

NCAA: Stricter Rules, Significant Consequences

The NCAA takes a notably stricter approach than the professional leagues. Cannabis remains prohibited for NCAA athletes, and testing occurs at championship events and bowl games. The NCAA threshold is 15 ng/mL — ten times lower than the WADA standard — meaning the window during which a past user could test positive is substantially wider.

A positive test at an NCAA championship event results in a one-year loss of eligibility for the first violation. Given the limited playing careers of most college athletes, a one-year suspension can be effectively career-ending. Athletes who test positive may also lose scholarships depending on their institution’s policies, as schools maintain their own drug testing programs separate from the NCAA.

There has been significant advocacy within college athletics for NCAA policy reform, particularly as states continue to legalize cannabis for adults aged 21 and over, and many college athletes are of legal consumption age. As of the time of writing, the NCAA has not moved to align its threshold with WADA or to adopt a treatment model.

Out-of-Competition Testing and Athlete Protections

Under WADA rules, out-of-competition cannabis use carries no anti-doping consequence for athletes subject to the World Anti-Doping Code. However, this protection does not apply to all athletes. Registered Testing Pool (RTP) athletes — typically elite internationals competing at the highest levels — are subject to whereabouts requirements and can be tested unannounced at any time. While the testing itself is out-of-competition, a positive collected 24 hours before competition could still fall within WADA’s defined in-competition period depending on timing.

For athletes in legal states competing under NFL, NBA, or NHL rules, the legal status of cannabis in their state offers some practical protection — not as a legal defense in league proceedings, but as context that shapes how violations are handled. A player in Colorado who tests positive is unlikely to be treated the same way as a player who tested positive for cocaine, and CBAs reflect this reality.

Athletes who use cannabis for therapeutic purposes (pain management, sleep, anxiety) should be aware that no therapeutic use exemption (TUE) process exists for cannabis under WADA. CBD use is permitted, but the athlete bears the burden of ensuring their CBD product does not contain prohibited cannabinoids above threshold levels.

CBD Use in Sports: Permitted but Not Risk-Free

WADA removed CBD from the Prohibited List effective 2018. Athletes may use CBD supplements, tinctures, and topicals without violating anti-doping rules. However, the practical risk lies in product quality and labeling accuracy.

Independent laboratory testing of commercially available CBD products has repeatedly found that many contain detectable THC above the labeled amount, and some full-spectrum products contain enough THC to cause a positive drug test at standard cutoffs, particularly with regular high-dose use. A 2020 study found roughly one in five CBD products tested exceeded 0.3% THC, and some contained no CBD at all.

For athletes subject to anti-doping rules, the practical guidance is:

Famous Cannabis Cases in Sports

Sha’Carri Richardson (2021): The US sprinter tested positive for THC at the US Olympic Trials following her mother’s death, receiving a 30-day suspension that excluded her from the Tokyo Olympics 100m event. The case sparked widespread debate about cannabis in sport and WADA’s in-competition prohibition, as the substance offered no performance enhancement in sprint events.

Ross Rebagliati (1998): The Canadian snowboarder initially had his Nagano Winter Olympics gold medal revoked after testing positive for cannabis, only to have it reinstated when it was determined that cannabis was not on the IOC’s Prohibited List at the time. The case prompted the IOC to add cannabis to its banned list.

Michael Phelps (2009): Images of the swimmer using a bong circulated widely. Phelps was not subject to an anti-doping violation (no in-competition test involved) but received a three-month suspension from USA Swimming and lost a major sponsorship deal. The case illustrated the reputational dimension of cannabis use in sport independent of formal drug testing.

Nick Diaz (UFC, 2015): The fighter received a five-year suspension (later reduced to 18 months) from the Nevada Athletic Commission after a third cannabis-related positive. The disproportionate initial sanction drew criticism and contributed to subsequent policy reform discussions in combat sports.

Implications for Athletes in Legal States

The patchwork of sports drug testing policies creates a confusing environment for athletes who live and train in states where adult-use cannabis is legal. A professional basketball player in California faces essentially no consequence for off-season cannabis use under NBA rules. A college basketball player at the same institution in California could lose a year of eligibility for the same behavior. A track and field athlete on the US Olympic team faces potential sanctions if they use cannabis within 12 hours of competition, regardless of state law.

State legal protections do not override sports governing body rules. Anti-doping authorities and leagues operate under private contractual frameworks, not state law. Athletes cannot rely on their state’s cannabis legalization as a shield in any anti-doping proceeding. The practical advice for competitive athletes at any level is to understand the specific rules governing their sport, consult with their sports organization’s medical or legal staff if using cannabis therapeutically, and apply conservative abstinence timelines before any competition or testing window.

Detection Windows Relevant to Sports Testing

The key variable for athletes subject to in-competition testing is understanding how long THC-COOH remains detectable in urine at the relevant cutoff. At WADA’s 150 ng/mL threshold, a single casual use would typically clear within 24–48 hours. At the NCAA’s 15 ng/mL threshold, the same single use may be detectable for 3–5 days.

For chronic heavy users, urine THC-COOH can persist well above 150 ng/mL for 7–14 days after cessation, and individual outliers have tested positive at lower thresholds for 30+ days due to THC’s lipophilic storage in adipose tissue. Athletes who use cannabis regularly during the off-season and transition into a competition season with testing need to account for these extended windows, not merely the last day of use.

Blood and oral fluid tests are used in some settings and have significantly shorter detection windows (24–72 hours for oral fluid; 12–36 hours for blood THC itself), but these matrices are less commonly used in anti-doping programs compared to urine. See our saliva drug test guide and blood THC detection timeline for full details.

Frequently Asked Questions

Is cannabis banned in all sports competitions?

Cannabis is prohibited in-competition by WADA for all sports following the World Anti-Doping Code, at a urinary threshold of 150 ng/mL THC-COOH. Out-of-competition use is not banned under WADA rules. Individual leagues (NFL, NBA, MLB) have their own negotiated policies that may be more or less restrictive.

What is the WADA threshold for cannabis?

WADA’s urinary threshold for 11-nor-delta9-THC-glucuronide is 150 ng/mL. This was raised from 15 ng/mL in 2013 to better distinguish in-competition intoxication from residual detection of prior recreational use.

Can NFL players use cannabis in the off-season?

Under the current NFL CBA, cannabis testing is restricted to a pre-season window from April 20 to August 9. Outside that window, the NFL does not test for cannabis unless a player is already in the intervention program. First positives trigger a treatment program, not suspension.

Is CBD allowed under WADA rules?

CBD itself has been permitted since 2018 and does not appear on the WADA Prohibited List. However, other cannabinoids including THC remain prohibited in-competition. Athletes using full-spectrum CBD products risk inadvertent THC exposure. WADA recommends broad-spectrum or isolate products with third-party CoA certification.

Share: